About QuantuMDx
QuantuMDx is a company based in Newcastle Upon Tyne (United Kingdom) founded in 2008.. QuantuMDx has raised $57.26 million across 6 funding rounds from investors including Gov.uk, British Business Bank and Adjuvo. QuantuMDx has completed 1 acquisition, including NorthGene. QuantuMDx offers products and services including Q-POC Platform, CAPTURE-XT, Respiratory Solution, and TB Host Immune Response Assay. QuantuMDx operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and OpGen, among others.
- Headquarter Newcastle Upon Tyne, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Quantumdx Group Limited
- Date of Incorporation 04 Mar, 2008
- Jurisdiction NEWCASTLE UPON TYNE, ENGLAND
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of QuantuMDx
QuantuMDx offers a comprehensive portfolio of products and services, including Q-POC Platform, CAPTURE-XT, Respiratory Solution, and TB Host Immune Response Assay. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid multiplex PCR system for point-of-care diagnostics.
Platform for capturing and processing diagnostic samples.
Assay for detecting respiratory infections like SARS-CoV-2.
Test for tuberculosis immune response detection.
Unlock access to complete
Unlock access to complete
Funding Insights of QuantuMDx
QuantuMDx has successfully raised a total of $57.26M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $19.18 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series D — $19.2M
-
First Round
First Round
(17 Oct 2013)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Series D - QuantuMDx | Valuation | Adjuvo |
|
| Mar, 2021 | Amount | Series C - QuantuMDx | Valuation |
investors |
|
| Jan, 2018 | Amount | Series B - QuantuMDx | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in QuantuMDx
QuantuMDx has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, British Business Bank and Adjuvo. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
London-based startups in CleanTech, Manufacturing, and Media sectors are funded.
|
Founded Year | Domain | Location | |
|
Private debt fund and fund of funds focused on startups
|
Founded Year | Domain | Location | |
|
Early-stage healthcare investments are made by 3B Future Health Fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by QuantuMDx
QuantuMDx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include NorthGene. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
DNA testing for legal, personal, and forensic purposes is provided.
|
1994 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - QuantuMDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Quantumdx Comparisons
Competitors of QuantuMDx
QuantuMDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and OpGen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| domain | founded_year | HQ Location |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
DNA sequencing platform for human genome analysis is developed.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing technologies for applied genomic testing and medical sequencing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Quantumdx
Frequently Asked Questions about QuantuMDx
When was QuantuMDx founded?
QuantuMDx was founded in 2008 and raised its 1st funding round 5 years after it was founded.
Where is QuantuMDx located?
QuantuMDx is headquartered in Newcastle Upon Tyne, United Kingdom.
Is QuantuMDx a funded company?
QuantuMDx is a funded company, having raised a total of $57.26M across 6 funding rounds to date. The company's 1st funding round was a Series B of $12M, raised on Oct 17, 2013.
What does QuantuMDx do?
QuantuMDx was founded in 2008 and is based in Newcastle Upon Tyne, United Kingdom. Operations focus on the diagnostics sector, where handheld and portable low-cost platforms for DNA analysis and virus detection are developed. The Q-POC device supports sequencing and diagnostic applications. Personalized healthcare delivery is enabled through these technologies, with emphasis on accessibility in clinical settings.
Who are the top competitors of QuantuMDx?
QuantuMDx's top competitors include Nanopore, PacBio and Complete Genomics.
What products or services does QuantuMDx offer?
QuantuMDx offers Q-POC Platform, CAPTURE-XT, Respiratory Solution, and TB Host Immune Response Assay.
How many acquisitions has QuantuMDx made?
QuantuMDx has made 1 acquisition, including NorthGene.
Who are QuantuMDx's investors?
QuantuMDx has 4 investors. Key investors include Gov.uk, British Business Bank, Adjuvo, and 3B Future Health Fund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.